“Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study” (2018) Biomolecules and Biomedicine, 18(2), pp. 185–190. doi:10.17305/bjbms.2017.2279.